[1]谈望晶 朱向东** 申 睿 刘 苗 安耀荣.溃疡性结肠炎与肠道菌群的研究进展[J].陕西中医药大学学报,2018,(02):109-114.[doi:10.13424/j.cnki.jsctcm.2018.02.033]
点击复制

溃疡性结肠炎与肠道菌群的研究进展()
分享到:

《陕西中医药大学学报》[ISSN:2096-1340/CN:61-1501/R]

卷:
期数:
2018年02期
页码:
109-114
栏目:
研究生园地
出版日期:
2018-03-10

文章信息/Info

文章编号:
2096-1340(2018)02-0109-06
作者:
谈望晶 朱向东** 申 睿 刘 苗 安耀荣
甘肃中医药大学,甘肃 兰州 730000
关键词:
溃疡性结肠炎 肠道菌群 微生态制剂 中医药
分类号:
R573. 1
DOI:
10.13424/j.cnki.jsctcm.2018.02.033
文献标志码:
A
摘要:
溃疡性结肠炎是一种炎症性肠病,临床以腹痛、腹泻、血便等症状为主,其病情极易反复,迁延难愈。 目前研究发现其发生与肠道菌群的失衡关系密切,通过调节失衡的肠道菌群可以起到治疗作用。结合文献,从 正常人的肠道菌群、溃疡性结肠炎患者肠道菌群的变化、肠道菌群在溃疡性结肠炎治疗中的作用、中医药调节肠 道菌群等方面进行综述,希望对溃疡性结肠炎与肠道菌群的关系有一个全新的认识。

参考文献/References:

[1]Kornbluth A; Sachar DB; Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults. American College of Gastroenterology,Practice Parameters Committee[J]. A- merican Journal of Gastroenterology,1997,99 ( 7) : 1371 - 85.
[2]Gordon,Morris,Farrell,et al. P - 054 Probiotics for Ma- intenance of Remission in Ulcerative Colitis: ,A Cochrane Systematic Review. [J]. Inflammatory Bowel Diseases, 2016,22.
[3]Dignass A,Eliakim R,Magro F,et al. [Second Europe- an evidence - based Consensus on the diagnosis and man- agement of ulcerative colitis Part 1: Definitions and diag- nosis ( Spanish version) ]. [J]. Revista De Gastroentero- logia De Mexico,2014,79( 4) : 140 - 151.
[4]杨泽云. 溃疡性结肠炎的发病机制与治疗进展[J]. 临 床合理用药杂志,2015,( 30) : 180 - 181.
[5]孙芳美. 溃疡性结肠炎的发病机制与治疗进展[J]. 中 国医药指南,2012,10( 12) : 445 - 447.
[6]Round J L,Mazmanian S K. The gut microbiota shapes intestinal immune responses during health and disease. [J]. Nature Reviews Immunology,2009,9 ( 5 ) : 313 - 323.
[7]Sartor R B,Brandtzaeg P,Isolauri E,et al. Microbial - host interactions in inflammatory bowel diseases and exper- imental colitis. [C]/ / Nestle Nutrition Workshop Series Paediatric Programme. 2009: 1031 - 1043.
[8]Eckburg P B,Bik E M,Bernstein C N,et al. Diversity of the human intestinal microbial flora[J]. Science,2005, 308( 5728) : 1635 - 1638.
[9]牛敏,邵天波,陈瑞春,等. 溃疡性结肠炎患者肠道菌 群分析和细菌毒素基因检测[J] 郑州大学学报( 医学 版) ,2015,59( 4) : 514 - 518.
[10]Tomasello G,Tralongo P,Damiani P,et al. Dismicro- bism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes. [J]. World Journal of Gastroenterology,2014,20( 48) : 18121.
[11]SWIDSINSKI A,LADHOFF A,PERNTHALER A,et al. Mucosal flora in inflammatory bowel disease [J]. Gas- troenterology,2002,122( 1) : 44 - 54.
[12]王振疆,陈渝萍. 炎症性肠病与肠黏膜屏障关系的研 究进展[J]. 右江医学,2015,43( 1) : 97 - 101.
[13]Ashwin N. Ananthakrishnan MD MPH, Emily L. McGinley MS MPH,Kia Saeian MD MSc Epi,et al. Tem- poral trends in disease outcomes related to Clostridium dif- ficile,infection in patients with inflammatory bowel dis- ease[J]. Inflammatory Bowel Diseases,2011,17 ( 4 ) : 976 – 983.
[14]Thomazini C M,Samegima D A,Rodrigues M A,et al. High prevalence of aggregative adherent Escherichia coli strains in the mucosa - associated microbiota of patients with inflammatory bowel diseases.[J]. International Jour- nal of Medical Microbiology Ijmm,2011,301 ( 6 ) : 475 - 9.
[15]Thomson J M,Hansen R,Berry S H,et al. Enterohe- patic helicobacter in ulcerative colitis: potential pathogenic entities[J]. Plos One,2012,6( 2) : e17184.
[16]白鹏,吕愈敏,顾芳. 细菌 16SrDNA 荧光定量 PCR 法 分析溃疡性结肠炎患者肠道菌群变化[J]. 胃肠病学 和肝病学杂志,2008,17( 7) : 566 - 571.
[17]王艳,李俊霞,王化虹,等. 溃疡性结肠炎肠道菌群 失调与免疫球蛋白水平的相关性[J]. 实用医学杂志, 2016,32( 10) : 1631 - 1634.
[18]孙勇,丁彦青. 溃疡性结肠炎患者肠道菌群与病理变 化关系的探讨[J]. 现代消化及介入诊疗,2009,14 ( 1) : 26 - 28.
[19]褚源,王巧民. 不同分期溃疡性结肠炎患者黏膜相关 菌群的变化及意义[J]. 安徽医科大学学报,2014,49 ( 10) : 1444 - 1447.
[20]韩晓霞,侯天舒,杨阳,等. 葡聚糖硫酸钠致溃疡性 结肠炎大鼠模型的肠道微生态[J]. 世界华人消化杂 志,2012( 35) : 3445 - 3451.
[21]Nishikawa J,Kudo T,Sakata S,et al. Diversity of mu- cosa - associated microbiota in active and inactive ulcera- tive colitis. [J]. Scandinavian Journal of Gastroenterolo- gy,2009,44( 2) : 180 - 186
[22]Rajilic' - Stojanovic' M,Shanahan F,Guarner F,et al. Phylogenetic analysis of dysbiosis in ulcerative colitis dur- ing remission. [J]. Inflammatory Bowel Diseases,2013, 19( 3) : 481 - 488.
[23]Andoh A,Imaeda H,Aomatsu T,et al. Andoh A, Imaeda H,Aomatsu T,et al. Comparison of the fecal mi- crobiota profiles between ulcerative colitis and Crohn ’s disease using terminal restriction fragment length polymor- phism analysis[J]. Journal of Gastroenterology,2011,46 ( 4) : 479 - 486.
[24]邱春雷,严红,吴雄健,等. 溃疡性结肠炎的微生态 学改变及双歧杆菌的治疗作用研究[J]. 中国全科医 学,2014,17( 26) : 3077 - 3082.
[25]蒋曼,高鸿亮,姚萍. RT - PCR 技术定量检测新疆溃 疡性结肠炎患者肠道菌群的改变[J]. 世界华人消化 杂志,2014,22( 4) : 596 - 600.
[26]Machiels K,Joossens M,Sabino J,et al. A decrease of the butyrate - producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. [J]. Gut,2014,63 ( 8 ) : 1275 - 1283.
[27]宋军民,杨超,常远,等. 炎症性肠病患者肠道菌群 变化与发病关系 研 究[J]. 中 华 医 院 感 染 学 杂 志, 2015,25( 15) : 3425 - 3427.
[28]刘翔,丁元伟,林虹. 溃疡性结肠炎患者肠道不同病 变部位 Toll 样受体 4 的表达[J]. 中国现代医学杂志, 2015,25( 18) : 38 - 40.
[29]Neuman M G. Immune dysfunction in inflammatory bowel disease.[J]. Translational Research,2007,149( 4) : 173 - 186.
[30]王俊珊,刘占举. 炎症性肠病的诊断和药物治疗相关 指南解 读[J]. 世 界 临 床 药 物,2015,36 ( 12) : 809 - 813.
[31]Thompsonchagoyán O C,Maldonado J,Gil A. Aetiology of inflammatory bowel disease ( IBD) : role of intestinal microbiota and gut - associated lymphoid tissue immune response. [J]. Clinical Nutrition,2005,24 ( 3 ) : 339 - 52.
[32]张峰睿,缪应雷. 微生态制剂与炎症性肠病[J]. 世 界华人消化杂志,2013,18( 27) : 2792 - 2801.
[33]Sang L X,Chang B,Zhang W L,et al. Remission in- duction and maintenance effect of probiotics on ulcerative colitis: A meta - analysis[J]. 世界胃肠病学杂志( 英文 版) ,2010,16( 15) : 1908 - 1915.
[34]王聪恋,殷桂香. 微生态制剂在轻中度溃疡性结肠炎 治疗中的临床疗效[J]. 世界华人消化杂志,2016,24 ( 17) : 2731 - 2736.
[35]Sood A,Midha V,Makharia G K,et al. The Probiotic Preparation,VSL #3 Induces Remission in Patients With Mild - to - Moderately Active Ulcerative Colitis - Clinical Gastroenterology and Hepatology[J]. Clinical Gastroenter- ology & Hepatology the Official Clinical Practice Journal of the American Gastroenterological Association,2009,7 ( 11) : 1202 - 1209.
[36]Fujimori S,Tatsuguchi A,Gudis K,et al. High dose probiotic and prebiotic cotherapy for remission induction of active Crohn’s disease[J]. Journal of Gastroenterology and Hepatology,2007,22( 8) : 1199 - 1204.
[37]Tursi A,Brandimarte G,Papa A,et al. Treatment of re- lapsing mild - to - moderate ulcerative colitis with the pro- biotic VSL #3 as adjunctive to a standard pharmaceutical treatment: a double - blind,randomized,placebo - con- trolled study.[J]. American Journal of Gastroenterology, 2010,105( 10) : 2218 - 2227.
[38]张发明,范志宁,季国忠. 粪菌移植的概念、历史、现 状和未 来[J]. 中 国 内 镜 杂 志,2012,18 ( 9) : 930 - 934.
[39]Kellermayer R. Prospects and challenges for intestinal microbiome therapy in pediatric gastrointestinal disorders. [J]. World Journal of Gastrointestinal Pathophysiology, 2013,4( 4) : 91 - 93.
[40]Donohue D C. Safety of probiotics. [J]. Asia Pacific Journal of Clinical Nutrition,2006,15( 4) : 563 - 569.
[41]Liu CQ,Wu W,Wu RJ,et al. A case of ulcerative coli- tis treated by fecalmicrobiota transplantation[J]. Chin J Dig,2013,33( 12) : 873.
[42]Bennet J D,Brinkman M. Bennet JD,Brinkman M. Treatment of ulcerative colitis by implantation of normal colonic flora. Lancet. 1: 164 [J]. Lancet, 1989, 1 ( 8630) : 164.
[43]Borody T J,Warren E F,Leis S,et al. Treatment of ul- cerative colitis using fecal bacteriotherapy.[J]. Journal of Clinical Gastroenterology,2003,37( 1) : 42 - 47.
[43]Borody T J,Warren E F,Leis S,et al. Treatment of ul- cerative colitis using fecal bacteriotherapy.[J]. Journal of Clinical Gastroenterology,2003,37( 1) : 42 - 47.
[44]Moayyedi P,Surette M G,Kim P T,et al. Fecal Micro- biota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial [J]. Gastroenterology,2015,149( 1) : 102 - 109.
[45]崔伯塔,王敏,季国忠,等. 粪菌移植: 公元 4 世纪至 2013 年[J]. 世界华人消化杂志,2013,21 ( 30) : 3222 - 3229.
[46]Hideki K,Koji Y,Tomoyuki I,et al. Failure of Fecal Microbiota Transplantation in a Three - Year - Old Child with Severe Refractory Ulcerative Colitis: [J]. Pediatric Gastroenterology Hepatology & Nutrition,2016,19 ( 3 ) : 214 - 220.
[47]刘力,张欢. 肠道菌群失调与溃疡性结肠炎[J]. 现代中医药,2010,30( 2) : 45 - 47.
[48]Guo M,Ding S,Zhao C,et al. Red Ginseng and Semen Coicis can improve the structure of gut microbiota and re- lieve the symptoms of ulcerative colitis. [J]. Journal of Ethnopharmacology,2014,162( 10) : 7 – 13.
[49]史权,薛艳华,赵光远,等. 对大鼠肠道菌群有调整 作用的中药筛选[J]. 黑龙江医药科学,2005,28( 1) : 28 - 30.
[50]梁金花,郑科文,金大伟. 黄芪多糖对溃疡性结肠炎 大鼠肠道菌群调节作用的研究[J]. 中国中医药科技, 2012,19( 4) : 331 - 332.
[51]Wang X M,Lu Y,Wu L Y,et al. Moxibustion inhibits interleukin - 12 and tumor necrosis factor alpha and modu- lates intestinal flora in rat with ulcerative colitis [J]. World Journal of Gastroenterology,2012,18 ( 46 ) : 6819 - 6828.
[52]侯天舒,韩晓霞,杨阳,等. 电针对溃疡性结肠炎大 鼠肠道微生态的保护作用[J]. 针刺研究,2014,39 ( 1) : 27 - 34.
[53]刘伟,刘翔,林漫鹏,等. 溃疡性结肠炎患者正常与 病变肠段肠道菌群比较[J]. 湖北民族学院学报( 医学 版) ,2011,28( 1) : 4 - 6.
[54]Naidoo K,Gordon M,Fagbemi A O,et al. Probiotics for maintenance of remission in ulcerative colitis. [J]. Co- chrane Database of Systematic Reviews, 2011, 7 ( 12) : CD007443. Phylogenetic analysis of dysbiosis in ulcerative colitis dur- ing remission. [J]. Inflammatory Bowel Diseases,2013, 19( 3) : 481 - 488.
[9]牛敏,邵天波,陈瑞春,等. 溃疡性结肠炎患者肠道菌 群分析和细菌毒素基因检测[J] 郑州大学学报( 医学 版) ,2015,59( 4) : 514 - 518.
[10]Tomasello G,Tralongo P,Damiani P,et al. Dismicro- bism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes. [J]. World Journal of Gastroenterology,2014,20( 48) : 18121.
[11]SWIDSINSKI A,LADHOFF A,PERNTHALER A,et al. Mucosal flora in inflammatory bowel disease [J]. Gas- troenterology,2002,122( 1) : 44 - 54.
[12]王振疆,陈渝萍. 炎症性肠病与肠黏膜屏障关系的研 究进展[J]. 右江医学,2015,43( 1) : 97 - 101.
[13]Ashwin N. Ananthakrishnan MD MPH, Emily L. McGinley MS MPH,Kia Saeian MD MSc Epi,et al. Tem- poral trends in disease outcomes related to Clostridium dif- ficile,infection in patients with inflammatory bowel dis- ease[J]. Inflammatory Bowel Diseases,2011,17 ( 4 ) : 976 – 983.
[14]Thomazini C M,Samegima D A,Rodrigues M A,et al. High prevalence of aggregative adherent Escherichia coli strains in the mucosa - associated microbiota of patients with inflammatory bowel diseases.[J]. International Jour- nal of Medical Microbiology Ijmm,2011,301 ( 6 ) : 475 - 9.
[15]Thomson J M,Hansen R,Berry S H,et al. Enterohe- patic helicobacter in ulcerative colitis: potential pathogenic entities[J]. Plos One,2012,6( 2) : e17184.
[16]白鹏,吕愈敏,顾芳. 细菌 16SrDNA 荧光定量 PCR 法 分析溃疡性结肠炎患者肠道菌群变化[J]. 胃肠病学 和肝病学杂志,2008,17( 7) : 566 - 571.
[17]王艳,李俊霞,王化虹,等. 溃疡性结肠炎肠道菌群 失调与免疫球蛋白水平的相关性[J]. 实用医学杂志, 2016,32( 10) : 1631 - 1634.
[18]孙勇,丁彦青. 溃疡性结肠炎患者肠道菌群与病理变 化关系的探讨[J]. 现代消化及介入诊疗,2009,14 ( 1) : 26 - 28.
[19]褚源,王巧民. 不同分期溃疡性结肠炎患者黏膜相关 菌群的变化及意义[J]. 安徽医科大学学报,2014,49 ( 10) : 1444 - 1447.
[20]韩晓霞,侯天舒,杨阳,等. 葡聚糖硫酸钠致溃疡性 结肠炎大鼠模型的肠道微生态[J]. 世界华人消化杂 志,2012( 35) : 3445 - 3451.
[21]Nishikawa J,Kudo T,Sakata S,et al. Diversity of mu- cosa - associated microbiota in active and inactive ulcera- tive colitis. [J]. Scandinavian Journal of Gastroenterolo- gy,2009,44( 2) : 180 - 186

相似文献/References:

[1]孙雨晴1  查安生2.查安生教授肠病治肝理论溃疡性结肠炎中的辨治浅析[J].陕西中医药大学学报,2019,(04):015.[doi:10.13424/j.cnki.jsctcm.2019.04.005]
[2]李一芳1  王 睿2 查安生2 王 键1  孙 娟 1.地马煎剂对肠道湿热型溃疡性结肠炎8-异前列腺素F2α的调控作用研究[J].陕西中医药大学学报,2019,(04):086.[doi:10.13424/j.cnki.jsctcm.2019.04.022]
[3]冯 智王 俊 李毅忠廖 超 唐学贵*.溃疡性结肠炎“血水同病”模型的建立及评价[J].陕西中医药大学学报,2018,(02):081.[doi::10.13424/j.cnki.jsctcm.2018.02.024]
 Feng Zhi.The Establishment and Evaluation of “Simultaneous Blood and Water Syndromes”Model of Ulcerative Colitis[J].Journal of Shaanxi University of Traditional Chinese Medicine,2018,(02):081.[doi::10.13424/j.cnki.jsctcm.2018.02.024]
[4]时丹丹 王乾 谢培 闫曙光 徐珊 梁西红.半夏泻心汤及其拆方对 TNBS致溃疡性结肠炎模型大鼠结肠组织细胞因子的影响[J].陕西中医药大学学报,2018,(05):114.[doi:DOI:10.13424/j.cnki.jsctcm.2018.05.034]
 Shi Dandan,Wang Qian,Xie Pei,et al.Effects of Banxia Xiexin Decoction and Its Disassembled Prescriptions on Cytokines in Colonic Tissue of Rats with Ulcerative Colitis Induced by TNBS[J].Journal of Shaanxi University of Traditional Chinese Medicine,2018,(02):114.[doi:DOI:10.13424/j.cnki.jsctcm.2018.05.034]
[5]樊振 李瑞 袁敏惠 杜晓泉.肠宁方并中药灌肠治疗慢性复发型轻中度溃疡性结肠炎临床研究[J].陕西中医药大学学报,2018,(06):050.[doi:10.13424/j.cnki.jsctcm.2018.06.017]
[6]袁敏惠 马小兵 杜晓泉.张锡纯治痢方对辨治溃疡性结肠炎的启示[J].陕西中医药大学学报,2018,(06):113.[doi:10.13424/j.cnki.jsctcm.2018.06.035]
[7]杨薪博 张 伟 吴洁琼.青柏溃结汤灌肠对溃疡性结肠炎活动期血清炎症因子的影响研究[J].陕西中医药大学学报,2017,(04):042.[doi:10.13424/j.cnki.jsctcm.2017.04.014]
[8]杨 杰,姜小艳,李 健.理肠汤结合溃疡灵灌肠治疗脾虚湿困型溃疡性结肠炎40例[J].陕西中医药大学学报,2019,(03):108.[doi:10.13424/j.cnki.jsctcm.2019.03.028]
[9]钟兴腾 安耀荣 朱向东 柳荣 高艳奎 王欢.以《周易·损卦》象数思维解析论治溃疡性结肠炎[J].陕西中医药大学学报,2020,(5):040.[doi:10.13424/j.cnki.jsctcm.2020.05.010]
 Zhong Xingteng,An Yaorong,Zhu Xiangdong,et al.A Discussion on the Treatment of UC Based on the Image – numerology Thinking in Zhouyi Sungua[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(02):040.[doi:10.13424/j.cnki.jsctcm.2020.05.010]
[10]李敏 刘肖 徐小波 李天然.甘草泻心汤联合血竭对DSS诱导的UC模型大鼠的抗炎作用[J].陕西中医药大学学报,2022,(01):077.[doi:10.13424/j.cnki.jsctcm.2022.01.017]
 LI Min LIU Xiao XU Xiaobo LI Tianran.Anti Inflammatory Effect of Gancao Xiexin Decoction Combined with Dragons Blood on DSS Induced UC Model Rats[J].Journal of Shaanxi University of Traditional Chinese Medicine,2022,(02):077.[doi:10.13424/j.cnki.jsctcm.2022.01.017]

备注/Memo

备注/Memo:
收稿日期: 2017 - 03 - 24 编辑: 巩振东
更新日期/Last Update: 2019-12-10